The DOI matches its Crossref record; 41 of the 41 references it cites were found in a registry or an index.
Multiparametric plasma EV profiling facilitates diagnosis of pancreatic malignancy
Open accessAbstract
A multiplexed plasmonic assay analyzes circulating tumor-derived extracellular vesicles for detection of pancreatic ductal adenocarcinoma.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Regression shrinkage and selection via the lasso
Tibshirani, R. (1996) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1996.tb02080.x · Cited by 51,482
DeLong, E. R., DeLong, D. M., & Clarke-Pearson, D. L. (1988) · Biometrics · doi:10.2307/2531595 · Cited by 22,649
Regularization and Variable Selection Via the Elastic Net
Zou, H., & Hastie, T. (2005) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.1467-9868.2005.00503.x · Cited by 20,957
Regularization Paths for Generalized Linear Models via Coordinate Descent
Friedman, J., Hastie, T., & Tibshirani, R. (2010) · Journal of Statistical Software · doi:10.18637/jss.v033.i01 · Cited by 19,927
Detection of Circulating Tumor DNA in Early- and Late-Stage Human Malignancies
Bettegowda, C., Sausen, M., Leary, R. J., Kinde, I., Wang, Y., Agrawal, N., Bartlett, B. R., Wang, H., Luber, B., Alani, R. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007094 · Cited by 5,067
Self-citationGlypican-1 identifies cancer exosomes and detects early pancreatic cancer
Melo, S. A., Luecke, L. B., Kahlert, C., Fernandez, A. F., Gammon, S. T., Kaye, J., LeBleu, V. S., Mittendorf, E. A., Weitz, J., Rahbari, N., et al. (2015) · Nature · doi:10.1038/nature14581 · Cited by 2,880
Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver
Costa-Silva, B., Aiello, N. M., Ocean, A. J., Singh, S., Zhang, H., Thakur, B. K., Becker, A., Hoshino, A., Mark, M. T., Molina, H., et al. (2015) · Nature Cell Biology · doi:10.1038/ncb3169 · Cited by 2,692
Label-free detection and molecular profiling of exosomes with a nano-plasmonic sensor
Im, H., Shao, H., Park, Y. I., Peterson, V. M., Castro, C. M., Weissleder, R., & Lee, H. (2014) · Nature Biotechnology · doi:10.1038/nbt.2886 · Cited by 1,321
Self-citationProtein typing of circulating microvesicles allows real-time monitoring of glioblastoma therapy
Shao, H., Chung, J., Balaj, L., Charest, A., Bigner, D. D., Carter, B. S., Hochberg, F. H., Breakefield, X. O., Weissleder, R., & Lee, H. (2012) · Nature Medicine · doi:10.1038/nm.2994 · Cited by 759
Self-citationChip-based analysis of exosomal mRNA mediating drug resistance in glioblastoma
Shao, H., Chung, J., Lee, K., Balaj, L., Min, C., Carter, B. S., Hochberg, F. H., Breakefield, X. O., Lee, H., & Weissleder, R. (2015) · Nature Communications · doi:10.1038/ncomms7999 · Cited by 612
Self-citationExtracellular vesicle sizing and enumeration by nanoparticle tracking analysis
Gardiner, C., Ferreira, Y. J., Dragovic, R. A., Redman, C. W. G., & Sargent, I. L. (2013) · Journal of Extracellular Vesicles · doi:10.3402/jev.v2i0.19671 · Cited by 584
TCPA: a resource for cancer functional proteomics data
Li, J., Lu, Y., Akbani, R., Ju, Z., Roebuck, P. L., Liu, W., Yang, J.-Y., Broom, B. M., Verhaak, R. G. W., Kane, D. W., et al. (2013) · Nature Methods · doi:10.1038/nmeth.2650 · Cited by 512
Madhavan, B., Yue, S., Galli, U., Rana, S., Gross, W., Müller, M., Giese, N. A., Kalthoff, H., Becker, T., Büchler, M. W., et al. (2015) · International Journal of Cancer · doi:10.1002/ijc.29324 · Cited by 495
Tumor markers in pancreatic cancer: a European Group on Tumor Markers (EGTM) status report
Duffy, M. J., Sturgeon, C., Lamerz, R., Haglund, C., Holubec, V. L., Klapdor, R., Nicolini, A., Topolcan, O., & Heinemann, V. (2010) · Annals of Oncology · doi:10.1093/annonc/mdp332 · Cited by 381
SCS macrophages suppress melanoma by restricting tumor-derived vesicle–B cell interactions
Pucci, F., Garris, C., Lai, C. P., Newton, A., Pfirschke, C., Engblom, C., Alvarez, D., Sprachman, M., Evavold, C., Magnuson, A., et al. (2016) · Science · doi:10.1126/science.aaf1328 · Cited by 349
Self-citationConsensus on biomarkers for neuroendocrine tumour disease
Oberg, K., Modlin, I. M., De Herder, W., Pavel, M., Klimstra, D., Frilling, A., Metz, D. C., Heaney, A., Kwekkeboom, D., Strosberg, J., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(15)00186-2 · Cited by 283
Koopmann, J., Zhang, Z., White, N., Rosenzweig, J., Fedarko, N., Jagannath, S., Canto, M. I., Yeo, C. J., Chan, D. W., & Goggins, M. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1167-3 · Cited by 282
A Mouse to Human Search for Plasma Proteome Changes Associated with Pancreatic Tumor Development
Faca, V. M., Song, K. S., Wang, H., Zhang, Q., Krasnoselsky, A. L., Newcomb, L. F., Plentz, R. R., Gurumurthy, S., Redston, M. S., Pitteri, S. J., et al. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050123 · Cited by 257
Micro-NMR for Rapid Molecular Analysis of Human Tumor Samples
Haun, J. B., Castro, C. M., Wang, R., Peterson, V. M., Marinelli, B. S., Lee, H., & Weissleder, R. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002048 · Cited by 214
Self-citationTumor markers CA19-9, CA242 and CEA in the diagnosis of pancreatic cancer: a meta-analysis.
Zhang, Y., Yang, J. J., Li, H., Wu, Y., Zhang, H., & Chen, W. (2015) · PubMed · Cited by 208
New biomarkers and targets in pancreatic cancer and their application to treatment
Costello, E., Greenhalf, W., & Neoptolemos, J. P. (2012) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2012.119 · Cited by 195
Circulating Tumor Cells As Prognostic Markers in Neuroendocrine Tumors
Khan, M. S., Kirkwood, A., Tsigani, T., Garcia-Hernandez, J., Hartley, J. A., Caplin, M. E., & Meyer, T. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.2905 · Cited by 185
Diagnosis by extracellular vesicles
Théry, C. (2015) · Nature · doi:10.1038/nature14626 · Cited by 158
Sequential Validation of Blood-Based Protein Biomarker Candidates for Early-Stage Pancreatic Cancer
Capello, M., Bantis, L. E., Scélo, G., Zhao, Y., Peng, L., Dhillon, D. S., Patel, N. J., Kundnani, D. L., Wang, H., Abbruzzese, J. L., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djw266 · Cited by 153
Shin, S. J., Smith, J. A., Rezniczek, G. A., Pan, S., Chen, R., Brentnall, T. A., Wiche, G., & Kelly, K. A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1309720110 · Cited by 111
Modelling the benefits of early diagnosis of pancreatic cancer using a biomarker signature
Ghatnekar, O., Andersson, R., Svensson, M., Persson, U., Ringdahl, U., Zeilon, P., & Borrebaeck, C. A. K. (2013) · International Journal of Cancer · doi:10.1002/ijc.28256 · Cited by 85
Opportunities and Challenges for Pancreatic Circulating Tumor Cells
Nagrath, S., Jack, R. M., Sahai, V., & Simeone, D. M. (2016) · Gastroenterology · doi:10.1053/j.gastro.2016.05.052 · Cited by 75
Rahib, L., Fleshman, J. M., Matrisian, L. M., & Berlin, J. D. (2016) · JAMA Oncology · doi:10.1001/jamaoncol.2016.0585 · Cited by 73
Glypican-1 in exosomes as biomarker for early detection of pancreatic cancer.
Herreros‐Villanueva, M., & Bujanda, L. (2016) · Europe PMC (PubMed Central) · doi:10.3978/j.issn.2305-5839.2015.10.39 · Cited by 67
Klein‐Scory, S., Tehrani, M. M., Eilert-Micus, C., Adamczyk, K. A., Wojtalewicz, N., Schnölzer, M., Hahn, S. A., Schmiegel, W., & Schwarte‐Waldhoff, I. (2014) · Proteome Science · doi:10.1186/s12953-014-0050-5 · Cited by 57
Fauci, J. M., Sabbatino, F., Wang, Y., Londoño-Joshi, A. I., Straughn, J. M., Landen, C. N., Ferrone, S., & Buchsbaum, D. J. (2013) · Gynecologic Oncology · doi:10.1016/j.ygyno.2013.10.038 · Cited by 55
Self-citationAlderton, G. K. (2015) · Nature reviews. Cancer · doi:10.1038/nrc3990 · Cited by 46
Circulating Metabolites and Survival Among Patients With Pancreatic Cancer
Yuan, C., Clish, C. B., Wu, C. H., Mayers, J. R., Kraft, P. L., Townsend, M. K., Zhang, M., Tworoger, S. S., Bao, Y., Qian, Z. R., et al. (2016) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djv409 · Cited by 38
Exosomes: novel implications in diagnosis and treatment of gastrointestinal cancer
Rahbari, M., Rahbari, N. N., Reißfelder, C., Weitz, J., & Kahlert, C. (2016) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-016-1468-2 · Cited by 37
Precision medicine in pancreatic cancer — fact or fiction?
Seufferlein, T., & Mayerle, J. (2016) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2015.215 · Cited by 35 · cited 2×
“Various approaches to achieving this are being explored (5, 6), including the use of CA242 (3), circulating tumor cells (7), circulating tumor-derived extracellular vesicles (tEVs), which include exosomes (8), metabolites (9) and proteomic analyses (10, 11), and circulating DNA (12).”
BackgroundResultDiagnostic and prognostic biomarkers in pancreatic carcinoma.
Liang, J. J., Kimchi, E. T., Staveley-O’Carroll, K. F., & Tan, D. (2009) · PubMed · Cited by 32
Intracellular antigens as targets for antibody based immunotherapy of malignant diseases
Wang, Y., Wang, X., Ferrone, C. R., Schwab, J. H., & Ferrone, S. (2015) · Molecular Oncology · doi:10.1016/j.molonc.2015.10.019 · Cited by 24
Self-citationGlypican-1 as a highly sensitive and specific pancreatic cancer biomarker
Diamandis, E. P., & Plebani, M. (2015) · Clinical Chemistry and Laboratory Medicine (CCLM) · doi:10.1515/cclm-2015-0773 · Cited by 21
Kelly, K. A., Hollingsworth, M. A., Brand, R. E., Liu, C. H., Singh, V. K., Srivastava, S., Wasan, A. D., Yadav, D. K., & Andersen, D. K. (2015) · Pancreas · doi:10.1097/mpa.0000000000000552 · Cited by 19
Rapid Characterization of Candidate Biomarkers for Pancreatic Cancer Using Cell Microarrays (CMAs)
Kim, M., Kuppireddy, S. V., Sakamuri, S., Singal, M., Getnet, D., Gowda, H., Goel, R., Balakrishnan, L., Jacob, H. K. C., Kashyap, M. K., et al. (2012) · Journal of Proteome Research · doi:10.1021/pr300483r · Cited by 14
Yanagisawa, K., Tomida, S., Matsuo, K., Arima, C., Kusumegi, M., Yokoyama, Y., Ko, S. B. H., Mizuno, N., KAWAHARA, T., Kuroyanagi, Y., et al. (2012) · International Journal of Proteomics · doi:10.1155/2012/510397 · Cited by 6
Cited by
The biology , function , and biomedical applications of exosomes
Kalluri, R., & LeBleu, V. S. (2020) · Science · doi:10.1126/science.aau6977 · Cited by 10,770
“…of GPC1 (glypican 1) – positive exosomes in the diagnosis of pancreatic, breast, and colon cancer, with GPC1 being enriched in cancer cell – derived exosomes, thus enabling the detection of cancer and possibly response to therapy (decrease in exosome numbers and thustumorburden)( 207 – 216 ).”
New Technologies for Analysis of Extracellular Vesicles
Shao, H., Im, H., Castro, C. M., Breakefield, X., Weissleder, R., & Lee, H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00534 · Cited by 1,675
Self-citationGoggins, M., Overbeek, K. A., Brand, R., Syngal, S., Del Chiaro, M., Bartsch, D. K., Bassi, C., Carrato, A., Farrell, J., Fishman, E. K., et al. (2020) · Gut · doi:10.1136/gutjnl-2019-319352 · Cited by 659
The evolving translational potential of small extracellular vesicles in cancer
Möller, A., & Lobb, R. J. (2020) · Nature Reviews Cancer · doi:10.1038/s41568-020-00299-w · Cited by 544
Tian, Y., Ma, L., Gong, M., Su, G., Zhu, S., Zhang, W., Wang, S., Li, Z., Chen, C., Li, L., et al. (2018) · ACS Nano · doi:10.1021/acsnano.7b07782 · Cited by 491
Metadata
- Authors
- Yang, K. S., Im, H., Hong, S., Pergolini, I., del Castillo, A. F., Wang, R., Clardy, S., Huang, C.-H., Pille, C., Ferrone, S., Yang, R., Castro, C. M., Lee, H., del Castillo, C. F., & Weissleder, R.
- Venue
- Science Translational Medicine
- Published
- 2017-05-24
- Volume
- 9
- Issue
- 391
- ISSN
- 1946-6234 (ISSN-L)
- 1946-6242
- OpenAlex
- W2619475721
- Cited by
- 277
- References
- 41
- FWCI
- 10.19
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.